This cancer information summary provides an overview of the use of Cannabis and its components as a treatment for people with cancer-related symptoms caused by the disease itself or its treatment.
Many of the medical and scientific terms used in this summary are hypertext linked at first use in each section to the NCI Dictionary of Cancer Termswhich is oriented toward nonexperts. When a linked term is clicked, a definition will appear in a separate window. Reference citations in some PDQ cancer information summaries may include links to external websites that are operated by individuals or organizations for the purpose of marketing or advocating the use of specific treatments or products.
These reference citations are included for informational purposes only. Their inclusion should not be viewed as an endorsement of the content of the websites, or of any treatment or product, by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board or the National Cancer Institute.
Cannabisalso known as marijuanaoriginated in Central Asia but is grown worldwide today. In the United States, it is a controlled substance and is classified as a Schedule I agent a drug with a high potential for abuse, and no currently accepted medical use. The Cannabis plant produces a resin containing psychoactive compounds called cannabinoidsin addition to other compounds found in plants, such as terpenes and flavonoids. The highest concentration of cannabinoids is found in the female flowers of the plant.
The U. The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep. Cannabinoids are a group of terpenophenolic compounds found in Cannabis species e. This summary will review the role of Cannabis and the cannabinoids in the treatment of people with cancer and disease-related or treatment-related side effects.
Cannabis use for medicinal purposes dates back at least 3, years. Its use was promoted for reported analgesicsedativeanti-inflammatoryantispasmodic, and anticonvulsant effects. Inthe U. Treasury Department introduced the Marihuana Tax Act. Physicians in the United States were the principal opponents of the Act. The American Medical Association AMA opposed the Act Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya physicians were required to pay a special tax for prescribing Cannabisuse special order forms to procure it, and keep special records concerning its professional use.
In addition, the AMA believed that objective evidence that Cannabis was harmful was lacking and that passage of the Act would impede further research into its medicinal worth. Pharmacopoeia because of persistent concerns about its potential to cause harm. InCongress passed the Boggs Act, which for the first time included Cannabis with narcotic drugs. Inwith the passage of the Controlled Substances Act, Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya was classified by Congress as a Schedule I drug.
Drugs in Schedule I are distinguished as having no currently accepted medicinal use in the United States. Despite its designation as having no medicinal use, Cannabis was distributed by the U. Distribution of Cannabis through this program was closed to new patients in Additional states have legalized only one ingredient in Cannabissuch as cannabidiol CBDand are not included in the map.
Some medical marijuana laws are broader than others, and there is state-to-state variation in the types of medical conditions for which treatment is allowed. The main psychoactive constituent of Cannabis was identified as deltatetrahydrocannabinol THC. Inan isomer of synthetic deltaTHC in sesame oil was licensed and approved for the treatment of chemotherapy -associated nausea and vomiting under the generic name dronabinol. Clinical trials determined that dronabinol was as effective as or better than other antiemetic agents available at the time.
Thus, the indications were expanded to include treatment of anorexia associated with human immunodeficiency virus infection in Clinical trial results showed no statistically significant weight gain, although patients reported an improvement in appetite. In recent decades, the neurobiology of cannabinoids has been analyzed. A second cannabinoid receptor, CB2, was identified in The highest expression of CB2 receptors is located on B lymphocytes and natural killer cellssuggesting a possible role in immunity.
Endogenous cannabinoids endocannabinoids have been identified and appear to have a role in pain modulation, control of movement, feeding behavior, mood, bone growth, inflammationneuroprotection, and memory. Cannabinoids are a group of carbon—containing terpenophenolic compounds produced uniquely by Cannabis species e.
Although deltatetrahydrocannabinol THC is the primary psychoactive ingredient, other known compounds with biologic activity are cannabinol, cannabidiol CBDcannabichromene, cannabigerol, tetrahydrocannabivarin, and deltaTHC.
CBD, in particular, is thought to have significant analgesicanti-inflammatoryand anxiolytic activity without the psychoactive effect high of deltaTHC. One study in mice and rats suggested that cannabinoids may have a protective effect against the development of certain types of tumors.
A dose-related decrease in the incidence of hepatic adenoma tumors and hepatocellular carcinoma HCC was Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya in the Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya. Decreased incidences of benign tumors polyps and adenomas in other organs mammary glanduteruspituitarytestisand pancreas were also noted in the rats.
In another study, deltaTHC, deltaTHC, and cannabinol were found to inhibit the growth of Lewis lung adenocarcinoma cells in vitro and in vivo. Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.
For example, these compounds have been shown to induce apoptosis in glioma cells in culture and induce regression of glioma tumors in mice and rats, while they protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor. Similar to findings in glioma cells, the cannabinoids were shown to trigger cell death through stimulation of an endoplasmic reticulum stress pathway that activates autophagy and promotes apoptosis.
Other investigations have confirmed that CB1 and CB2 receptors may be potential targets in non-small cell lung carcinoma [ 16 ] and breast cancer.
An in vitro study of the effect of CBD on programmed cell death in breast cancer cell lines found that CBD induced programmed cell death, independent of the CB1, CB2, or vanilloid receptors. CBD inhibited the survival of both estrogen receptor—positive and estrogen receptor—negative breast cancer cell lines, inducing apoptosis in a concentration-dependent manner while having little effect on nontumorigenic mammary cells.
CBD has also been demonstrated to exert a chemopreventive effect in a mouse model of colon cancer. Animals treated with azoxymethane and CBD concurrently were protected from developing premalignant and malignant lesions.
In Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya vitro experiments involving colorectal cancer cell lines, the investigators found that CBD protected DNA from oxidative damage, increased endocannabinoid levels, and reduced cell proliferation. In a subsequent study, the investigators found that the antiproliferative effect of CBD was counteracted by selective CB1 but not CB2 receptor antagonistssuggesting an involvement of CB1 receptors.
In an in vivo model using severe combined immunodeficient mice, subcutaneous tumors were generated by inoculating the animals with cells from human non-small cell lung carcinoma cell lines. Tumor specimens revealed that THC had antiangiogenic and antiproliferative effects.
However, research with immunocompetent murine tumor models has demonstrated immunosuppression and enhanced tumor growth in mice treated with THC. In addition, both plant-derived and endogenous cannabinoids have been studied for anti- inflammatory effects. A mouse study demonstrated that endogenous cannabinoid system signaling is likely to provide intrinsic protection against colonic inflammation. CBD may also enhance uptake of cytotoxic drugs into malignant cells.
Activation of the transient receptor potential vanilloid type 2 TRPV2 has been shown to inhibit proliferation of human glioblastoma multiforme cells and overcome resistance to the chemotherapy agent carmustine. This suggests that coadministration of CBD with cytotoxic agents may increase drug uptake and Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya cell death in human glioma cells. Also, CBD together with THC may enhance the antitumor activity of classic chemotherapeutic drugs such as temozolomide in some mouse models of cancer.
Preclinical research suggests that emetic circuitry is tonically controlled by endocannabinoids. The antiemetic action of cannabinoids is believed to be mediated via interaction with the 5-hydroxytryptamine 3 5-HT3 receptor.
CB1 receptor antagonists have been shown to elicit emesis in the least shrew that is reversed by cannabinoid agonists. In the latter model, CBD was also shown to be efficacious.
Many animal studies have previously demonstrated that deltaTHC and other cannabinoids have a stimulatory effect on appetite and increase food intake. It is believed that the endogenous cannabinoid system may serve as a regulator of feeding behavior. The endogenous cannabinoid anandamide potently enhances appetite in mice. Understanding the mechanism of cannabinoid-induced analgesia has been increased through the study of cannabinoid receptors, endocannabinoids, and synthetic agonists and antagonists.
Cannabinoids produce analgesia through supraspinal, spinal, and peripheral modes of action, acting on both ascending and descending pain pathways. Similar to opioid receptors, increased levels of the CB1 receptor are found in regions of the brain that regulate nociceptive processing. With the development of receptor-specific antagonists, additional information about the roles of the Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya and endogenous cannabinoids in the modulation of pain has been obtained.
Cannabinoids may also contribute to pain modulation through Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya anti-inflammatory mechanism; a CB2 effect with cannabinoids acting on mast cell receptors to attenuate the release of inflammatory agents, such as histamine and serotoninand on keratinocytes to enhance the release of analgesic opioids has been described.
Cannabinoids have been shown to prevent chemotherapy-induced neuropathy in animal models exposed to paclitaxelvincristineor cisplatin. The endocannabinoid system is believed to be centrally involved in the regulation of mood and the extinction of aversive memories. Animal studies have shown Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya to have anxiolytic properties. It was shown in rats that these anxiolytic properties are mediated through unknown mechanisms.
The endocannabinoid system has also been shown to play a key role in the modulation of the sleep-waking cycle in rats. Inhaled cannabinoids are rapidly absorbed into the bloodstream with a peak concentration in 2 to 10 minutes, declining rapidly for a period of 30 minutes and with less generation of the psychoactive OH metabolite.
Cannabinoids are known to interact with the hepatic cytochrome P enzyme system. Because CBD is a potential inhibitor of certain cytochrome P enzymeshighly concentrated CBD oils used concurrently with conventional therapies that are metabolized by these enzymes could potentially increase toxicity or decrease the effectiveness of these therapies. A number of studies have yielded conflicting evidence regarding the risks of various cancers associated with Cannabis smoking.
A pooled analysis of three case-cohort studies of men in northwestern Africa cases and controls showed a significantly increased risk of lung cancer among tobacco smokers who also inhaled Cannabis. A large, retrospective cohort study of 64, men aged 15 to 49 years from the United States found that Cannabis use was not associated with tobacco-related cancers and a number of other Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya malignancies.
However, the study did find that, among nonsmokers of tobacco, ever Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya used Cannabis was associated with an increased risk of prostate cancer.
A population-based case-control study of lung cancer patients revealed that chronic low Cannabis exposure was not associated with an increased risk of lung cancer or other upper aerodigestive tract cancers and found no positive associations with any cancer type oralpharyngeallaryngeallung, or esophagus when adjusting for several confounders, including cigarette smoking.
A systematic review assessing 19 studies that evaluated premalignant or malignant lung lesions in persons 18 years or older who inhaled Cannabis concluded that observational studies failed to demonstrate statistically significant associations between Cannabis inhalation and lung cancer after adjusting for tobacco use. Epidemiologic studies examining one association of Cannabis use with head and neck squamous cell carcinomas have also been inconsistent in their findings. A pooled analysis of nine case-control Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannya from the U.
Compared with those who never smoked CannabisCannabis smokers had an elevated risk of oropharyngeal cancers and a reduced risk of tongue cancer. These study results both reflect the inconsistent effects of cannabinoids on cancer incidence noted in previous studies and suggest that more work needs to be done to understand the potential role of human papillomavirus infection.
With a hypothesis that chronic marijuana use produces adverse effects on the human endocrine and reproductive systemsthe association between Cannabis use and incidence of testicular germ cell tumors TGCTs has been examined. In a study of 49, Swedish men aged 19 to 21 years enrolled in the military between andparticipants were asked once at the time of conscription about their use of Cannabis and were followed up for 42 years. Limitations of the study were that it relied on indirect assessment of Cannabis use; and no information was collected on Cannabis use after the conscription-assessment period or on whether the testicular cancers were seminoma or nonseminoma subtypes.
These reports established the need for larger, well-powered, prospective Il cancro della prostata 2 cucchiai form method progresuyucha lіkuvannyaespecially studies evaluating the role of endocannabinoid signaling and cannabinoid receptors in TGCTs. During 16 years of follow-up89 Cannabis users 0.